The reason for this phenomenon seems to be that the previously reported anti-allergic effect such as inhibiting IL-4 and CD4+ of SCRT and its ingredients (Ikeda et al., 2002) affected the progression and remission of atopic dermatitis. This evidence concerns the gene CD4 and atopic eczema.